Article Sidebar
Main Article Content
PPARγ Activates Autophagy by Suppressing the PI3K–AKT1–FOXO3 Signaling Pathway and thus Alleviates Hepatic Ischemia-Reperfusion Injury
Main Article Content
Abstract
Background/Aims: Hepatic ischemia-reperfusion injury (HIRI) refers to the damage caused by metabolic imbalance post-ischemia upon reperfusion, often occurring in scenarios like hemorrhagic shock, liver resection, and liver transplantation. Due to the complex nature of the mechanisms underlying metabolic imbalance, specific treatment options are lacking. Peroxisome proliferator activated receptor gamma (PPARγ) is a group of metabolic regulatory receptors that can influence HIRI by regulating autophagy, although the precise mechanism remains contentious.
Materials and Methods: In vivo and in vitro experiments were conducted to simulate hypoxic conditions, evaluating the effects of PPARγ overexpression plasmids, autophagy inhibitors, phosphatidylinositol 3-kinase (PI3K) activators, and PPARγ agonists on HIRI. The activation status of the PI3K–AKT1–FOXO3 signaling pathway, autophagy levels, inflammatory responses, and liver cell/organ damage were analyzed using western blot, ELISA, flow cytometry, H&E staining, and TUNEL experiments.
Results: Peroxisome proliferator activated receptor gamma can mitigate cell damage caused by hypoxia by activating autophagy, with the activation of autophagy being associated with the inhibition of the PI3K–AKT1–FOXO3 signaling pathway. Additionally, pretreatment of mice with the PPARγ agonist rosiglitazone can alleviate HIRI induced by ischemia by inhibiting the activation of the PI3K–AKT1–FOXO3 signaling pathway to induce autophagy.
Conclusion: Peroxisome proliferator activated receptor gamma inhibited the PI3K-AKT1-FOXO3 signaling pathway, which in turn activated autophagy to alleviate HIRI.
Cite this article as: Liu X, Cui H, Song X, Shen W, Yan B. PPARγ activates autophagy by suppressing the PI3K–AKT1–FOXO3 signaling pathway and thus alleviates hepatic ischemia-reperfusion injury. Turk J Gastroenterol. Published online April 21, 2025. doi 10.5152/tjg.2025.2452919
Article Details
References
1. Jiménez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Peralta C. Inflammasome-mediated inflammation in liver ischemia-reperfusion injury. Cells. 2019;8(10):1131. [CrossRef]
2. Hirao H, Nakamura K, Kupiec-Weglinski JW. Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity. Nat Rev Gastroenterol Hepatol. 2022;19(4):239-256. [CrossRef]
3. Cannistrà M, Ruggiero M, Zullo A, et al. Hepatic ischemia reperfusion injury: a systematic review of literature and the role of current drugs and biomarkers. Int J Surg. 2016;33(suppl 1):S57-S70. [CrossRef]
4. Marion-Letellier R, Savoye G, Ghosh S. Fatty acids, eicosanoids and PPAR gamma. Eur J Pharmacol. 2016;785:44-49. [CrossRef]
5. Sheng W, Wang Q, Qin H, et al. Osteoarthritis: role of peroxisome proliferator-activated receptors. Int J Mol Sci. 2023;24(17):13137. [CrossRef]
6. Chen H, Tan H, Wan J, et al. PPAR-gamma signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets. Pharmacol Ther. 2023;245:108391. [CrossRef]
7. Wang S, Dougherty EJ, Danner RL. PPARgamma signaling and emerging opportunities for improved therapeutics. Pharmacol Res. 2016;111:76-85. [CrossRef]
8. Stark JM, Coquet JM, Tibbitt CA. The role of PPAR-gamma in allergic disease. Curr Allergy Asthma Rep. 2021;21(11):45. [CrossRef]
9. Kuboki S, Shin T, Huber N, et al. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology. 2008;47(1):215-224. [CrossRef]
10. Ruan W, Liu Q, Chen C, Li S, Xu J. [Limb remote ischemic preconditioning attenuates liver ischemia reperfusion injury by activating autophagy via modulating PPAR-gamma pathway]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41(9):918-928. [CrossRef]
11. El-Marasy SA, Mostafa RE, Mabrok HB, Khattab MS, Awdan SAE. Protective effect of irbesartan against hepatic ischemia-reperfusion injury in rats: role of ERK, STAT3, and PPAR-gamma inflammatory pathways in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(2):1681-1693. [CrossRef]
12. Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14(10):648. [CrossRef]
13. Kitada M, Koya D. Autophagy in metabolic disease and ageing. Nat Rev Endocrinol. 2021;17(11):647-661. [CrossRef]
14. Li J, Yu D, He C, et al. KLF6 alleviates hepatic ischemia-reperfusion injury by inhibiting autophagy. Cell Death Dis. 2023;14(7):393. [CrossRef]
15. Li H, Chen Y, Ding M, Yan Z, Guo W, Guo R. Pectolinarigenin attenuates hepatic ischemia/reperfusion injury via activation of the PI3K/AKT/Nrf2 signaling pathway. Chem Biol Interact. 2023;386:110763. [CrossRef]
16. Chai YL, Xu JZ, Zhang YL, Sheng GT. Effects of Probucol on cultured human umbilical vein endothelial cells injured by hypoxia/reoxygenation. Genet Mol Res. 2016;15(1):15016752. [CrossRef]
17. Wu L, Yu Q, Cheng P, Guo C. PPARgamma plays an important role in acute hepatic ischemia-reperfusion injury via AMPK/mTOR pathway. PPAR Res. 2021;2021:6626295. [CrossRef]
18. Li TT, Luo YH, Yang H, et al. FBXW5 aggravates hepatic ischemia/reperfusion injury via promoting phosphorylation of ASK1 in a TRAF6-dependent manner. Int Immunopharmacol. 2021;99:107928. [CrossRef]
19. Lee JW, Nam H, Kim LE, et al. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy. 2019;15(5):753-770. [CrossRef]
20. Choi EK, Lim DG. Hepatic ischemia-reperfusion injury with respect to oxidative stress and inflammatory response: a narrative review. J Yeungnam Med Sci. 2023;40(2):115-122. [CrossRef]
21. Huang Z, Pu J, Luo Y, et al. FAM49B, restrained by miR-22, relieved hepatic ischemia/reperfusion injury by inhibiting TRAF6/IKK signaling pathway in a Rac1-dependent manner. Mol Immunol. 2022;143:135-146. [CrossRef]
22. Huang Z, Zheng D, Pu J, et al. MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-kappaB pathway. Biosci Biotechnol Biochem. 2019;83(5):829-835. [CrossRef]
23. Huang Z, Mou T, Luo Y, et al. Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB. Cell Death Dis. 2020;11(6):455. [CrossRef]
24. Bi J, Zhang J, Ren Y, et al. Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress. Redox Biol. 2019;20:296-306. [CrossRef]
25. Liu X, Zhang P, Song X, Cui H, Shen W. PPARgamma mediates protective effect against hepatic ischemia/reperfusion injury via NF-kappaB pathway. J Invest Surg. 2022;35(8):1648-1659. [CrossRef]
26. Chen J, Liu H, Zhang X. [Protective effects of rosiglitazone on hepatic ischemia reperfusion injury in rats]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(7):732-737. [CrossRef]
27. Demir EA, Tutuk O, Dogan-Gocmen H, et al. CREB1 and PPARalpha/gamma pathways in hepatic ischemia/reperfusion: route for curcumin to hepatoprotection. Iran J Pharm Res. 2022;21(1):e133779. [CrossRef]
28. Zhu S, Wang X, Chen H, et al. Hippo (YAP)-autophagy axis protects against hepatic ischemia-reperfusion injury through JNK signaling. Chin Med J (Engl). 2024;137(6):657-668. [CrossRef]
29. Kong E, Li Y, Geng X, Wang J, He Y, Feng X. Ischemic preconditioning attenuates endoplasmic reticulum stress-dependent apoptosis of hepatocytes by regulating autophagy in hepatic ischemia-reperfusion injury. Int Immunopharmacol. 2023;122:110637. [CrossRef]
30. Zuo X, Wei X, Ju C, et al. Protective effect of photobiomodulation against hydrogen peroxide-induced oxidative damage by promoting autophagy through inhibition of PI3K/AKT/mTOR pathway in MC3T3-E1 cells. Oxid Med Cell Longev. 2022;2022:7223353. [CrossRef]
31. Chen K, Li JJ, Li SN, et al. 15-deoxy-Delta(12,14)-prostaglandin J(2) alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy. Acta Pharmacol Sin. 2017;38(5):672-687. [CrossRef]
32. Xiang S, Chen K, Xu L, Wang T, Guo C, Exerts B. Bergenin Exerts Hepatoprotective effects by inhibiting the release of inflammatory factors, apoptosis and autophagy via the PPAR-gamma pathway. Drug Des Devel Ther. 2020;14:129-143. [CrossRef]
33. Xu Z, Han X, Ou D, et al. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020;104(2):575-587. [CrossRef]
34. Omorou M, Huang Y, Gao M, et al. The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury. Cell Mol Life Sci. 2023;80(4):102. [CrossRef]
35. Liu T, Zhang Q, Mo W, et al. The protective effects of shikonin on hepatic ischemia/reperfusion injury are mediated by the activation of the PI3K/Akt pathway. Sci Rep. 2017;7:44785. [CrossRef]